The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is characterised by the progressive deposition of excessive extracellular matrix proteins within the lung parenchyma and represents the most rapidly progressive and fatal of all fibrotic conditions. Current anti-fibrotic drugs approved for the treatment of IPF fai...

Descripción completa

Detalles Bibliográficos
Autores principales: Platé, Manuela, Guillotin, Delphine, Chambers, Rachel C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488186/
https://www.ncbi.nlm.nih.gov/pubmed/33060168
http://dx.doi.org/10.1183/16000617.0269-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488186/
https://www.ncbi.nlm.nih.gov/pubmed/33060168
http://dx.doi.org/10.1183/16000617.0269-2020

Ejemplares similares